Changeflow GovPing Healthcare Drug dose cartridge for an inhaler device
Routine Notice Added Final

Drug dose cartridge for an inhaler device

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3939639A1 for Syqe Medical Ltd., covering a drug dose cartridge designed for an inhaler device. The invention relates to A61M classifications for medical devices and A61K pharmaceutical formulations, with designations across 31 European states including Germany, France, GB, Italy, and Spain.

What changed

EPO published international patent application EP3939639A1 designating 31 European states, covering a drug dose cartridge for an inhaler device. The patent claims priority from December 2021 and classifies under A61M 11/04, A61K 9/00, and A61M 15/00, indicating pharmaceutical inhalation delivery technology.

Medical device manufacturers and pharmaceutical companies developing inhalation drug delivery systems should conduct freedom-to-operate analyses. The patent provides Syqe Medical exclusivity over the cartridge design across major European markets including Germany, France, UK, Italy, Spain, Netherlands, and 26 other designated states through the patent term.

What to do next

  1. Review patent claims for freedom-to-operate analysis
  2. Monitor related patent family members
  3. Assess design-around opportunities

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DRUG DOSE CARTRIDGE FOR AN INHALER DEVICE

Publication EP3939639A1 Kind: A1 Apr 01, 2026

Applicants

Syqe Medical Ltd.

Inventors

Davidson, Perry, Schorr, Aaron, Schwartz, Binyamin, Lifshitz, Roee

IPC Classifications

A61M 11/04 20060101AFI20211213BHEP A61K 9/00 20060101ALI20211213BHEP A61M 15/00 20060101ALI20211213BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
April 1st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3939639A1

Who this affects

Applies to
Medical device makers Pharmaceutical companies
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent filing IP licensing Medical device innovation
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.